Related Experiment Video
Updated: Dec 12, 2025

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
A CNS-Targeting Prodrug Strategy for Nuclear Receptor Modulators
Skylar J Ferrara1, Thomas S Scanlan1
1Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, United States.
This study introduces a prodrug strategy to deliver carboxylic acid drugs, like nuclear receptor modulators, across the blood-brain barrier. The approach utilizes fatty acid amide hydrolase (FAAH) to target central nervous system (CNS) delivery for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Pharmacology
- Drug Delivery
Background:
- The blood-brain barrier (BBB) restricts central nervous system (CNS) drug entry, particularly for carboxylic acid-containing compounds.
- Nuclear receptor modulators are promising for neurodegenerative diseases but face BBB challenges.
- Targeted delivery to the CNS is crucial for effective neurotherapeutics.
Purpose of the Study:
- To develop a prodrug strategy for enhanced CNS penetration of carboxylic acid-based therapeutics.
- To mask peripheral activity while enabling CNS targeting of nuclear receptor modulators.
- To leverage specific enzyme activity within the CNS for prodrug activation.
Main Methods:
- Design of prodrugs with carboxylic acid moieties masked for peripheral circulation.
- Targeting of the enzyme fatty acid amide hydrolase (FAAH), which is enriched in the CNS.
- Evaluation of prodrug biodistribution and CNS penetration in relevant models.
- Assessment of prodrug conversion to active parent drug within the CNS.
Main Results:
- Demonstrated successful masking of peripheral receptor activity.
- Achieved significant CNS biodistribution of the prodrugs.
- Confirmed prodrug activation by CNS-enriched FAAH.
- Validated the strategy across diverse carboxylic acid-containing drug structures.
Conclusions:
- The described prodrug strategy effectively overcomes BBB limitations for CNS therapeutics.
- Targeting FAAH offers a viable route for CNS-specific drug delivery.
- This approach holds potential for treating neurodegenerative CNS diseases with improved efficacy and safety.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Regulation of Nuclear Protein Sorting
Prodrugs
Prodrugs help overcome...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Signal Transduction: Overview
Typically, signal transduction involves three...

